ライフサイエンスコーパス: PCT

1 PCT and CRP demonstrated to have a good negative predict

2 PCT appears to be a reliable indicator of infection.

3 PCT has also been studied in patients with sepsis in an

4 PCT has been studied as a diagnostic marker in different

5 PCT has performed better than C-reactive protein in some

6 PCT in this small cohort of PIIRS was associated with im

7 PCT is a reliable serum marker for determining the prese

8 PCT is more efficient and general than conventional tran

9 PCT may aid in diagnosing infection in challenging patie

10 PCT use was associated with increased antibiotic-days (a

11 PCT use was not associated with improved antibiotic use

12 PCT was <0.25 ng/mL in 19 (63.3%) patients.

13 PCT was also found to allow for unambiguous control of d

14 PCT was measured daily while in the ICU.

15 PCT was optimized for pressure and time, and it was foun

16 PCT-treated samples were clearly distinguished from the

17 PCTs exhibited a 5.5 times higher mutant frequency in la

18 PCTs placed from April 1, 1998, to December 31, 2009 (ti

19 PCTs were carried forward to GWAS ( approximately 2.5 mi

20 ons were fewer following PCT platelets (3.0% PCT versus 4.4% control; P =.02).

21 the incidence of grade 3 or 4 bleeding (4.1% PCT versus 6.1% control), were equivalent between the 2

22 to and partially redundantly with the CYY-1/PCT-1 pathway.

23 Primary analysis included 196 (PCT) versus 198 standard care patients.

24 ment of six biomarkers (IL-6, nCD64, IL-1ra, PCT, MCP1, and G-CSF) yielded the same predictive power

25 A total of 645 patients (318 PCT and 327 control) were evaluated.

26 nt, the incidence of grade 2 bleeding (58.5% PCT versus 57.5% control), and the secondary end point,

27 A PCT algorithm, including 0.1 ng/ml cut-off, determined a

28 35 of 53 days (66.0%) when the patient had a PCT less than 50000/muL and on 203 of 436 days (46.6%) w

29 3 of 436 days (46.6%) when the patient had a PCT of 50000/muL to 99000/muL.

30 l adults with undifferentiated infections, a PCT algorithm including 0.1 ng/ml cut-off did not achiev

31 recognize Cr(3+) in aqueous medium through a PCT mechanism.

32 y-nine patients (22%) achieved ALN pCR after PCT.

33 Mortality rates after PCT decreased over time.

34 ignificantly better than CRP (P < .0001) and PCT (P = .0001).

35 cterial tests were positive in 64 (18%), and PCT analysis identified bacterial infection in an additi

36 cates the cyclin-dependent kinases CDK-5 and PCT-1 and the cyclin CCY-1 in the regulation of the micr

37 spiratory symptoms >6 days (AUC = 0.79), and PCT <0.25 mug/L (AUC = 0.81) improved diagnostic perform

38 respiratory symptoms >6 days (AUC=0.79), and PCT <0.25 mug/L (AUC=0.81) improved diagnostic performan

39 Our results indicate that CRP and PCT are not suitable to distinguish UTI and ASB in nursi

40 CRP and PCT are the most promising, but neither is an ideal sing

41 CRP and PCT were tested simultaneously in the same study partici

42 od count (WBC), C-reactive protein (CRP) and PCT levels were measured in 3rd and 5th postoperative da

43 understand the competition between FRET and PCT.

44 sensitivities of CRP (cut-off 6.5 mg/L) and PCT (cut-off 0.025 ng/mL) were 52.3% (36.7-67.5%, 95%-CI

45 merged as promising systems for both PDT and PCT.

46 ProADM and PCT have promising roles in assisting clinicians in mana

47 ProADM and PCT levels were measured at onset of fever and then on d

48 The initial proADM and PCT levels were significantly higher in neutropenic pati

49 Follow-up, proADM, and PCT levels decreased significantly in response to antimi

50 tical fiber to yield a fiber sensor and anti-PCT detection antibody is conjugated to AuNPs to afford

51 In this study, anti-PCT capture antibody is functionalized on an unclad segm

52 Combination anthracycline/taxane-based PCT resulted in significantly more ALN pCRs, although ou

53 d States and to examine associations between PCT use and clinical outcomes.

54 e to dendrites in animals defective for both PCT-1 and CDK-5 pathways.

55 ised juice was highly rated compared to both PCT-treated and the fresh juice.

56 expressed at significantly higher levels by PCT were a number involved in NOTCH signaling, a finding

57 the intrasession repeatability of ACD, CCT, PCT at different nasal and temporal locations, WTW, and

58 ry breast tumors after primary chemotherapy (PCT) is associated with higher relapse-free survival (RF

59 ed with patients undergoing cholecystectomy, PCT patients had a higher rate of cardiovascular disease

60 Clinically, PCT levels may help in decisions regarding the need for

61 The objective of this study was to compare PCT and cholecystectomy outcomes over time.

62 Current PCT assays are rapid, specific, and of sufficient sensit

63 sphate: phosphocholine cytidylyltransferase (PCT), S-adenosylmethionine (SAM), and S-adenosylhomocyst

64 We sought to determine PCT use in critically ill patients with sepsis in the Un

65 thod shows a good correlation in determining PCT in blood plasma with the clinically validated electr

66 sis gene (Uro-d(+/-), Hfe(-/-)) that develop PCT with no treatments.

67 Furthermore, the developed PCT assay can be applied in whole human blood with an ad

68 e CriSTAL criteria tool to encourage earlier PCT referrals.

69 The study indicates a need for earlier PCT referral, showcases the potential to identify high r

70 transplantation, were transfused with either PCT-FFP or C-FFP for up to 7 days.

71 Transfusion reactions were fewer following PCT platelets (3.0% PCT versus 4.4% control; P =.02).

72 ivary samples were obtained and analyzed for PCT levels using highly sensitive double antibody sandwi

73 days to next transfusion were decreased for PCT compared with conventional platelets.

74 dence of grade 2 bleeding was equivalent for PCT and conventional platelets, although posttransfusion

75 limit of detection of 95 fg/mL (7.3 fM) for PCT.

76 Using a cutoff value of 0.3 ng/mL for PCT and 20 mg/L for CRP, negative likelihood ratios were

77 To investigate this hypothesis, we generated PCTs that harbored the transgenic shuttle vector, pUR288

78 re identified in 42% (63), and 83% (126) had PCT values of <0.25 microg/mL.

79 with PCT available, 3769 (18%) patients had PCT levels checked; 1119 (29.7%) had serial PCT measurem

80 arker of activation of innate immunity, high PCT levels affect clinical diagnosis, can be trended as

81 oradiologists evaluated NCT for hypodensity, PCT for infarct core and salvageable brain tissue, and C

82 proximately 2.5 million markers) to identify PCT-associated loci among 975 European American adult pa

83 We further assessed, if PCT can reflect early bacteremia induced by non-surgical

84 More importantly, PCT cycle analysis demonstrated that the MgH(2)-0.1TiH(2

85 this pathway, NOTCH signaling was blocked in PCT cell lines by treatment with a gamma-secretase inhib

86 Changes in PCT at the 12-o'clock position and best spectacle-correc

87 helial transport, were inversely enriched in PCT and mTAL.

88 ufficient sensitivity to detect increases in PCT serum levels within 4 to 6 h of initiation of infect

89 n of these genes influenced iron overload in PCT, we compared sequences of HAMP and HJV in 96 patient

90 lysis implicated several genetic pathways in PCT progression, including biphasic (up- and then down-r

91 ection, antibiotic exposure was shortened in PCT subjects with Streptococcus pneumoniae respiratory i

92 capture microdissection to collect incipient PCT cells and analyzed their global gene expression on A

93 ns, in the promotion of inflammation-induced PCT and suggest that small drug inhibitors of selenoprot

94 CS fates, and suggest that sim1a may inhibit PCT fate and/or negotiate the PCT/PST boundary.

95 Response to initial PCT has important potential as a guide to subsequent the

96 t decrease in mean (95% confidence interval) PCT change over time (-2.18 [-2.97 to -1.40 mum/year] an

97 The patent application number is PCT/US2016/036650'.

98 YY-1) and a cyclin-dependent Pctaire kinase (PCT-1) necessary for targeting presynaptic components to

99 to receive antibiotics based on PCT levels (PCT group) or a control group.

100 nd positive culture, the decline rate in log(PCT) over the first 72 hours independently predicted hos

101 Low PCT levels reflect little to no activation of an innate

102 We evaluated patients with AECOPD and low PCT concentrations to determine whether antibiotic thera

103 s hospitalized with nonsevere AECOPD and low PCT concentrations, antibiotic therapy beyond 24 hours d

104 th positive results of viral testing and low PCT values who were discharged receiving antibiotics (20

105 Mean PCT levels (saliva = 0.03 ng/mL and serum = 0.05 ng/mL)

106 8 to -0.67 mum/year], respectively) and mean PCT percent change over time (-3.32% [-4.36 to -2.27 mum

107 At baseline, the global mean PCT was significantly thinner in glaucoma patients than

108 there is no probe self-quenching and minimum PCT, efficient signal amplification is demonstrated desp

109 ranslocated Myc in the pathogenesis of mouse PCT, two signaling pathways also implicated in developme

110 with delayed-onset ADA-SCID using tandem-MS (PCT EP2010/070517) to evaluate levels of adenosine and 2

111 We were able to detect native PCT in patient samples and showed a good correlation (R(

112 tion who were evaluated on admission by NCT, PCT, and CTA, and underwent a follow-up CT/CTA or magnet

113 ictably high incidence (approximately 85% of PCT), and has a direct counterpart in humans: Burkitt ly

114 Abrogation of PCT was caused in part by the striking inhibition of the

115 The addition of PCT levels to bacterial culture and viral detection resu

116 Analysis of PCT use by instrumental variable and difference-in-diffe

117 odels were used to determine associations of PCT use with outcomes (antibiotic-days, incidence of Clo

118 acute stroke is afforded by a combination of PCT and CTA.

119 nephrons that were predominantly composed of PCT segments, but lacked the enlarged PST observed in RA

120 Serum concentrations of PCT and sTREM-1 and the PMN CD64 index were higher in pa

121 state of the art device for the detection of PCT.

122 evel meta-analysis to investigate effects of PCT-guided antibiotic management in patients with bacter

123 Programs to improve implementation of PCT-based strategies are warranted prior to widespread a

124 totally refractory to pristane induction of PCT.

125 kidney disease may alter baseline levels of PCT and thus result in inappropriate use of PCT in this

126 In addition, the serum levels of PCT were recorded at immediate and 1-hour post-NSPT.

127 Low levels of PCT, together with low CRP values, seem to be early and

128 may have implications for the management of PCT.

129 In this mouse model of PCT, AA suppresses hepatic URO accumulation at low, but

130 cytosolic extracts from two murine models of PCT: wild-type mice treated with iron, delta-aminolevuli

131 This study highlights the potential of PCT to avoid the genesis of off-flavours in fresh-like p

132 The gene expression profiles of PCT samples and those of undissected OG samples from adj

133 haracterized the transcriptional profiles of PCT, centroblastic diffuse large B-cell lymphomas (CBL),

134 ts and glaucoma patients in the mean rate of PCT change (P = .28) or PCT percentage change over time

135 to determine whether monitoring the rate of PCT change has a role in glaucoma management.

136 The rate of PCT thinning was calculated using mixed effects models.

137 This report of PCT detection is first of its kind among the electronic

138 ucted to evaluate the efficacy and safety of PCT-FFP compared with conventional FFP (C-FFP).

139 strikingly similar and quite unlike that of PCT.

140 The presence and timing of PCT referral as well as patient survival status to hospi

141 However, current use of PCT and associated outcomes in real-world clinical setti

142 This article focuses on the use of PCT in patients with various degrees of chronic kidney d

143 PCT and thus result in inappropriate use of PCT in this population.

144 mly assigned to receive antibiotics based on PCT levels (PCT group) or a control group.

145 %; SP = 97%), Increased mean transit time on PCT was predictive of the tissue at risk for infarction

146 Decreased cerebral blood volume on PCT was the most accurate predictor of final infarct vol

147 in the mean rate of PCT change (P = .28) or PCT percentage change over time (P = .23).

148 cular type of photoreactivity for PDT and/or PCT effects.

149 t a ratio of 1:1 to receive standard care or PCT-guided care and viral PCR testing.

150 han WBC but less accurate than either CRP or PCT.

151 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments

152 patients admitted with AECOPD who had a peak PCT concentration <0.25 ug/mL.

153 ) and, more recently, for photochemotherapy (PCT).

154 inactivate pathogens in fresh frozen plasma (PCT-FFP).

155 interleukin 6-dependent mouse plasmacytoma (PCT), is the premier model of cancer-associated chromoso

156 nslocations characteristic of plasmacytomas (PCT), little is known about genetic factors and signalin

157 Peritoneal plasmacytomas (PCTs) in strain BALB/c (C), the premier experimental mod

158 curve for biomarkers shows that in 3rd POD, PCT and CRP have similar area under the curve (AUC) (0.7

159 ), both better than WBC (0.601); in 5th POD, PCT has a better AUC than CRP and WBC (0.862 vs 0.806 vs

160 mbination of rituximab and polychemotherapy [PCT]), and outcome were recorded.

161 The pretransfusion PCT was at least 50000/muL for 653 of 998 transfusions (

162 ent of transformed plasma cells in a primary PCT also induced apoptosis.

163 Procalcitonin (PCT) has been shown to be a useful surrogate marker in i

164 Procalcitonin (PCT) is increasingly utilized to determine the presence

165 Procalcitonin (PCT) is synthesized by a large number of tissues and org

166 Procalcitonin (PCT) was &0.25 ng/ml in 52 (83%) EIA+ patients, suggesti

167 C-reactive protein (CRP) and procalcitonin (PCT) measured by Point-of-Care tests (PoCT) to diagnose

168 myeloid cells-1 (sTREM-1) and procalcitonin (PCT) were assayed, and the expression of the high-affini

169 bsolute neutrophil count, and procalcitonin (PCT), specifically PCT <0.25 mug/L, were statistically a

170 bsolute neutrophil count, and procalcitonin (PCT), specifically PCT <0.25 ug/L, were statistically as

171 , C - reactive protein (CRP), Procalcitonin (PCT) and Lipopolysaccharide-binding protein (LBP).

172 C), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6).

173 -6, C-reactive protein (CRP), procalcitonin (PCT), and soluble urokinase plasminogen activator recept

174 bservational study to test if Procalcitonin (PCT) might be an early and reliable marker of anastomoti

175 protein (CRP) (2-200 mug/mL), procalcitonin (PCT) (0.2-50 ng/mL), and interleukin 6 (IL-6) (2-2000 pg

176 measuring the serum level of procalcitonin (PCT) as a marker of bacterial infection.

177 y is to assess the ability of procalcitonin (PCT) to differentiate between periodontal health and Sta

178 es have shown that the use of procalcitonin (PCT) to guide the decision to initiate antibiotic therap

179 eveloped for the detection of procalcitonin (PCT), a sepsis marker.

180 eveloped for the detection of procalcitonin (PCT), a specific and early marker for sepsis and microbi

181 The role of procalcitonin (PCT), a widely used sepsis biomarker, in critically ill

182 plication to the detection of procalcitonin (PCT), an important biomarker for sepsis.

183 domized trials support use of procalcitonin (PCT)-based algorithms to decrease duration of antibiotic

184 tudies suggest that the serum procalcitonin (PCT) level may be used to guide antibiotic therapy.

185 The interpretation of serum procalcitonin (PCT) levels in septic patients is facilitated by reviewi

186 nary antigen tests, and serum procalcitonin (PCT) were done in nearly all cases.

187 The procalcitonin (PCT) assay is an accurate screening test for identifying

188 h recent growing attention to procalcitonin (PCT) and pro-adrenomedullin (proADM).

189 Whether procalcitonin (PCT)-guided antibiotic management in patients with posit

190 r necrosis factor receptor-1, procalcitonin [PCT], C-reactive protein [CRP]) activation pathways were

191 metastases were treated in five prospective PCT trials.

192 cantly shorter for 253 patients who received PCT-guided treatment than for 270 control patients (-2.8

193 alysis of patients with bacteremia receiving PCT-guided antibiotic management demonstrates lower anti

194 Moreover, human recombinant PCT (hrPCT) for use as a standard was developed in the n

195 tively, in patients who received a rituximab-PCT regimen compared with 48% and 38% in those who recei

196 teristics during both periods, but rituximab-PCT regimens were administered to 88.5% of the patients

197 s a result of the use of intensive rituximab-PCT regimens in most patients, including very elderly on

198 ariate analysis, treatment without rituximab-PCT was the only adverse prognostic factor (odds ratio,

199 itive correlation between serum and salivary PCT values to clinical attachment level (CAL) at P < 0.0

200 A second PCT passage further reduced the volatiles (36%) and is t

201 PCT levels checked; 1119 (29.7%) had serial PCT measurements.

202 Antibiotic therapy tailored to serial PCT measurements may shorten the antibiotic exposure wit

203 a positive bacterial assay result or a serum PCT level of >/= 0.25 ng/mL on admission or day 2 of hos

204 g the pathways that result in elevated serum PCT levels is necessary for interpretation and subsequen

205 Screening for serum PCT levels in patients with periodontitis could act not

206 alone or in combination, can increase serum PCT levels.

207 Post NSPT the mean serum PCT values increased from 1.854 ng/mL to 1.871 ng/mL at

208 e diagnostic and prognostic utility of serum PCT in children.

209 Recent studies endorse the use of serum PCT to detect invasive infection, to differentiate sepsi

210 Linear regression model showed serum PCT to be a significant predictor for CAL.

211 Thermal pasteurisation and a single PCT treatment caused substantial losses in total volatil

212 We identified six PCTs with distinct microbial community/IL-1beta structur

213 betes drug, metformin, was a potent specific PCT inhibitor in vitro.

214 count, and procalcitonin (PCT), specifically PCT <0.25 mug/L, were statistically associated with Mp i

215 count, and procalcitonin (PCT), specifically PCT <0.25 ug/L, were statistically associated with Mp in

216 These results suggest PCT-FFP supported hemostasis in the treatment of acquire

217 own to enhance both porphyria cutanea tarda (PCT) and experimental uroporphyria.

218 or risk factors for porphyria cutanea tarda (PCT) are alcohol consumption and homozygosity for the C2

219 Porphyria cutanea tarda (PCT), the most common form of porphyria in humans, is du

220 porphyria (AIP) and porphyria cutanea tarda (PCT).

221 on in patients with porphyria cutanea tarda (PCT).

222 New rat monoclonal antibodies targeting PCT were screened and characterized.

223 duled to meet with the palliative care team (PCT) and complete quality-of-life (QOL) and mood questio

224 l to stimulate earlier Palliative Care Team (PCT) referral served as an underlying goal, and investig

225 ion complicated with posterior capsule tear (PCT) may be associated with severe complications.

226 ofold continuous pressure change technology (PCT) applications on the volatiles and sensory character

227 issue lysis via pressure cycling technology (PCT) in a Barocycler, followed by proteomic analysis of

228 l by the use of pressure-cycling technology (PCT) to increase the speed and decrease the relative amo

229 , also known as pressure cycling technology (PCT), using a Barocycler NEP 2320 was compared with the

230 hat is based on pressure cycling technology (PCT).

231 Pressure-composition-temperature (PCT) analysis demonstrated that both the nanosize and th

232 [2.2.2.2]paracyclophane-1,9,17,25-tetraene (PCT), can stabilize the neutral state by local aromatici

233 Our objective was to demonstrate that PCT provides more controlled enzymatic digestion of prot

234 In addition, our results suggest that PCTs may represent a more accurate approach than cell li

235 The PCT approach performed at least as well as the conventio

236 The PCT assay has better diagnostic accuracy than CRP measur

237 The PCT assay offered an area under the curve (AUC) of ROC c

238 The PCT Shredder is a mechanical grinder that quickly breaks

239 eviewing the known stimuli that activate the PCT family of genes.

240 These methods use the Barocycler, the PCT Shredder, or both.

241 In conclusion, the PCT method was found to be much faster than using atmosp

242 nction studies, sim1a knockdown expanded the PCT and abrogated both the PST and CS populations.

243 C ROC curve for the detection of IBI for the PCT assay was significantly higher than that for the CRP

244 of shorter mean antibiotic durations in the PCT arm for patients infected with gram-positive organis

245 of 35 (18%) versus 31 (16%), P = 0.54 in the PCT versus standard care, respectively.

246 All practices in the PCT were invited to the LES initiative, which ensured av

247 1a may inhibit PCT fate and/or negotiate the PCT/PST boundary.

248 The diagnostic characteristics of the PCT assay, C-reactive protein (CRP) concentration, white

249 hanism underlying clinical expression of the PCT phenotype, namely oxidation of uroporphyrinogen to u

250 functionality, enabling combinations of the PCT Shredder and the Barocycler to be used to purify mit

251 terial infection (IBI); however, data on the PCT assay in very young infants are insufficient.

252 xpanded the PST and CS, while it reduced the PCT.

253 immunosensor showed high selectivity to the PCT analyte which was evident through control experiment

254 Mitochondria isolated using the PCT Shredder are shown to be comparable to controls.

255 bility requirements by both meeting with the PCT and completing QOL assessments at least 50% of the t

256 Four of the PCTs that developed in the newly generated translocation

257 junctive pulse corticosteroid taper therapy (PCT) consisting of intravenous methylprednisolone 1 gm d

258 ed by thermal pasteurisation and non-thermal PCT.

259 d measure peripapillary choroidal thickness (PCT) from circle scans centered on the optic nerve head.

260 ness (CCT) and peripheral corneal thickness (PCT), and Scheimpflug imaging calculating corneal volume

261 tral (CCT) and peripheral corneal thickness (PCT), white-to-white diameter (WTW), and irido-corneal a

262 patient-days (93.4%) with thrombocytopenia (PCT, <100000/muL) when a platelet transfusion was given

263 Thus, PCT-1 and CDK-5 pathways direct polarized trafficking of

264 Tailoring antibiotics to PCT levels may reduce the duration of therapy without in

265 This study compares proADM to PCT as diagnostic and prognostic biomarkers of infection

266 Antibodies specific to PCT were immobilized on the poly-3-hexylthiophene (P3HT)

267 Measuring together PCT and CRP significantly improves AL diagnosis in 5th P

268 beta) and derive periodontal complex traits (PCTs) via principal component analysis.

269 emonstrate a polymerase chain transcription (PCT) reaction that results in the exponential production

270 involvement of photoinduced charge transfer (PCT) as an energy wasting mechanism.

271 e mechanism of photoinduced charge transfer (PCT).

272 cZ mutant frequency in serially transplanted PCTs and phagocyte-induced lacZ mutations in B cells in

273 d to receive either photochemically treated (PCT) or conventional (control) platelets for up to 28 da

274 An ex vivo photochemical treatment (PCT) process was developed to inactivate pathogens in fr

275 Percutaneous cholecystostomy tube (PCT) placement serves as a treatment option for acute ch

276 The proximal convoluted tubule (PCT) and the medullary thick ascending limb (mTAL) in th

277 he proximal convoluted and straight tubules (PCT, PST).

278 We extracted nascent plasma cell tumor (PCT) cells from within inflammatory oil granulomas (OG)

279 eased from 36% to 12% in patients undergoing PCT (P = 0.001).

280 h the first time period, patients undergoing PCT in the second time period had lower American Society

281 total of 143 patients successfully underwent PCT placement in time period 2.

282 d a trial assessing the feasibility of using PCT algorithms with viral testing to guide antibiotic us

283 bacterial from nonbacterial pneumonia using PCT has shown to reduce antibiotic usage, length of stay

284 ormation of the inflammatory tissue in which PCT develop (pristane granuloma).

285 ty and negative predictive value for AL with PCT less than 2.7 and 2.3 ng/mL were, respectively, 91.7

286 e that the hepatic siderosis associated with PCT likely results from dysregulated HAMP.

287 otic or outcome improvements associated with PCT use.

288 Combined with PCT &0.25 ng/ml, LFA could reduce unnecessary antibacter

289 There has been very limited experience with PCT in this country, however.

290 l patients with sepsis in 107 hospitals with PCT available, 3769 (18%) patients had PCT levels checke

291 transfusions were given to VLBW infants with PCT greater than 50000/muL.

292 equences of HAMP and HJV in 96 patients with PCT and 88 HFE C282Y homozygotes with marked hepatic iro

293 on-related genes in a group of patients with PCT and hh.

294 Hepatic HAMP expression in patients with PCT was significantly reduced, regardless of HFE genotyp

295 cts of liver biopsy samples of patients with PCT.

296 aled exonic polymorphisms in 2 patients with PCT: heterozygosity for a G-->A transition (G71D substit

297 ents, who underwent phacoemulsification with PCT and sulcus implantation of SPA-IOL designed for both

298 liary sulcus during phacoemulsification with PCT rather than switching to another backup IOL demandin

299 e combining the PMN CD64 index together with PCT and sTREM-1 serum levels in diagnosing sepsis in the

300 n compared with patients with hh but without PCT with comparable iron overload.